Neurology ReviewsOpicinumab May Benefit Patients With Relapsing-Remitting MSNovember 23, 2016Multiple Sclerosis
Neurology ReviewsVitamin D as an Add-On Therapy May Improve MRI Outcomes in MSNovember 1, 2016Multiple Sclerosis
Clinical Neurology NewsMS relapse predictors identified after patients stop treatmentNovember 1, 2016Multiple Sclerosis
Neurology ReviewsLipoic Acid Reduces Brain Atrophy in Secondary Progressive MSOctober 31, 2016Multiple Sclerosis
Neurology ReviewsGenetic Variations May Affect Vitamin D Level and MS Relapse RateOctober 27, 2016Multiple Sclerosis
Neurology ReviewsChoosing Wisely Initiative Helps Physicians Provide Appropriate CareOctober 27, 2016Sleep MedicineHeadache & MigrainePediatricsTraumatic Brain InjuryMultiple SclerosisBusiness of Medicine
Clinical Neurology NewsGenetic risk score for low vitamin D may affect MS relapse rateOctober 18, 2016Multiple Sclerosis
Neurology ReviewsEfficacy of Cladribine Tablets Continues After Conversion to MSOctober 10, 2016Multiple Sclerosis
Neurology ReviewsEvaluation of Cortical Lesions Could Improve Diagnosis of MSOctober 3, 2016Multiple Sclerosis
Clinical Neurology NewsSmoking, vitamin D deficiency linked to early MS disabilityOctober 3, 2016Multiple Sclerosis
Clinical Neurology NewsFluoxetine fails to slow progressive multiple sclerosisOctober 3, 2016Multiple Sclerosis
